---
$id: https://graph.org.ai/products/commodity/51161572
$type: Product
source: UNSPSC
code: "51161572"
title: "Nivimedone sodium anhydrous"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Nivimedone sodium anhydrous

**UNSPSC Code**: 51161572
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a mast cell stabilizer with the molecular formula C11H8NO4.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 50HX07BAJU, chemically known as 1h-indene-1,3(2h)-dione, 5,6-dimethyl-2-nitro-, ion(1-), sodium (1:1), but more generally known as nivimedone sodium anhydrous, which bears US NIH Compound Identifier 64752. European Medicines Agency schedules nivimedone sodium anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09333MIG. Most nations, for tariff purposes, schedule nivimedone sodium anhydrous under HS 29147000. SMILES: CC1CC2C(CC1C)C(=O)C(=[N+]([O-])[O-])C2=O.[NA+].

